ARCHIVES

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

This article is from The Cancer Letter archive.

Vol. 14 No. 37 | September 23, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units

July 4, 1986

DCT To Announce June 1 Guidelines For CREG Program In Cell Kinetics Related To Chemo, Radiotherapy

April 25, 1975

Columbia Receives $1 Million ACS Grants

May 3, 1985

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993